AQR discloses 5.87% stake in agilon health
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
agilon health, inc. Schedule 13G reports that AQR Capital Management, LLC and its parent AQR Capital Management Holdings, LLC beneficially own 974,897 shares of common stock, representing 5.87% of the class. The filings list 894,587 shares of shared voting power and 974,897 shares of shared dispositive power.
Insights
Passive 13G disclosure: AQR reports a 5.87% stake in agilon health.
The Schedule 13G filing shows AQR and its holding company beneficially own 974,897 shares with shared voting power of 894,587. This filing is a passive ownership disclosure under Section 13(g) and does not indicate an active change in control.
Future filings could show directional trades if AQR moves from 13G to 13D reporting; current disclosures list voting and dispositive counts but do not state any planned transactions.
Key Figures
Key Terms
Schedule 13G regulatory
Beneficially owned financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does AQR hold in agilon health (AGL)?
Does this Schedule 13G mean AQR is seeking control of AGL?
Who filed the 13G for AGL and where are they organized?
Are the voting and dispositive powers held solely by AQR?
When was the Schedule 13G signed for agilon health?
AI-generated analysis. How Rhea-AI works. Not financial advice.